Skip to main content
Fig. 2 | The Journal of Headache and Pain

Fig. 2

From: Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control study

Fig. 2

Box plots of markers of axonal damage. The median and IQR of NfL, GFAP, and UCHL1 concentrations in pg/ml in CSF (upper row) and serum (lower row) of the 3 different cohorts are presented. There is no significant difference in any protein concentration, neither in serum nor in CSF, between the interictal, the ictal-collected sample of migraine patients, or the control cohort of non-migraine patients (for all p > 0.05)

Back to article page